Finance

Lists
CLDI:NYSEAMERICAN
Calidi Biotherapeutics Inc
$1.13
+1.59%
(+0.018) 1D
Sep 22, 10:26:41 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLDI...
Open
$1.11
High
$1.14
Low
$1.11
Mkt. cap
4.15M
Avg. vol.
86.02K
Volume
14.05K
52-wk high
$27.84
52-wk low
$1.05
EPS
-$98.26
Beta
1.32
Shares outstanding
2.58M
No. of employees
29
Open
$1.11
High
$1.14
Low
$1.11
Mkt. cap
4.15M
Avg. vol.
86.02K
Volume
14.05K
52-wk high
$27.84
52-wk low
$1.05
EPS
-$98.26
Beta
1.32
Shares outstanding
2.58M
No. of employees
29
News stories
From web sources and news partners
About Calidi Biotherapeutics Inc
CEO-
Employees29
Founded2014
Headquarters-
SectorBiotechnology
Websitecalidibio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.36M
2.36M
2.59M
2.56M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.69M
2.11M
1.60M
1.59M
Operating expense
5.05M
4.47M
4.19M
4.15M
Total operating expenses
5.05M
4.47M
4.19M
4.15M
Operating income
-5.05M
-4.47M
-4.19M
-4.15M
Other non operating income
-82.00K
303.00K
121.00K
30.00K
EBT including unusual items
-5.17M
-4.06M
-4.10M
-4.16M
EBT excluding unusual items
-5.17M
-4.30M
-4.10M
-4.16M
Income tax expense
10.00K
-2.00K
4.00K
5.00K
Effective tax rate
-0.19%
0.05%
-0.10%
-0.12%
Other operating expenses
-
-
-
-
Net income
-5.15M
-4.06M
-4.11M
-4.16M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-41.00K
-142.00K
-38.00K
-35.00K
Net interest expenses
-41.00K
-142.00K
-38.00K
-35.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.94M
-3.14M
-3.76M
-3.71M
Gain or loss from assets sale
-
-244.00K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps